{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:27:50Z","timestamp":1790616470981,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clineuro.2022.107198","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T19:13:53Z","timestamp":1646334833000},"page":"107198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The relationship among integrin alpha 7, CD133 and Nestin as well as their correlation with clinicopathological features and prognosis in astrocytoma patients"],"prefix":"10.1016","volume":"217","author":[{"given":"Changtai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.clineuro.2022.107198_bib1","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.clineuro.2022.107198_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s13311-017-0519-x","article-title":"Glioma subclassifications and their clinical significance","volume":"14","author":"Chen","year":"2017","journal-title":"Neurotherapeutics"},{"issue":"23","key":"10.1016\/j.clineuro.2022.107198_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239114","article-title":"Astrocytoma: a hormone-sensitive tumor?","volume":"21","author":"Hirtz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clineuro.2022.107198_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1200\/EDBK_238353","article-title":"Management for different glioma subtypes: are all low-grade gliomas created equal?","volume":"39","author":"Tom","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107198_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s10014-019-00343-0","article-title":"Pilomyxoid astrocytomas: a short review","volume":"36","author":"Kulac","year":"2019","journal-title":"Brain Tumor Pathol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11060-009-9935-z","article-title":"Rapid recurrence and malignant transformation of pilocytic astrocytoma in adult patients","volume":"95","author":"Ellis","year":"2009","journal-title":"J. Neurooncol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107198_bib7","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/fon.16.9","article-title":"Patient outcomes following second surgery for recurrent glioblastoma","volume":"12","author":"Brandes","year":"2016","journal-title":"Future Oncol."},{"key":"10.1016\/j.clineuro.2022.107198_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106735","article-title":"Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: a single-center retrospective series","volume":"207","author":"Montemurro","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107198_bib9","first-page":"241","article-title":"Roles of integrin in tumor development and the target inhibitors","volume":"17","author":"Li","year":"2019","journal-title":"Chin. J. Nat. Med."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004994","article-title":"Integrin structure, activation, and interactions","volume":"3","author":"Campbell","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107198_bib11","first-page":"69","article-title":"Integrin alpha7 correlates with worse clinical features and prognosis, and its knockdown inhibits cell proliferation and stemness in tongue squamous cell carcinoma","volume":"56","author":"Lv","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107198_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22979","article-title":"Integrin alpha7 high expression correlates with deteriorative tumor features and worse overall survival, and its knockdown inhibits cell proliferation and invasion but increases apoptosis in breast cancer","volume":"33","author":"Bai","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"8","key":"10.1016\/j.clineuro.2022.107198_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22973","article-title":"Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer","volume":"33","author":"Xia","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.clineuro.2022.107198_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.stem.2017.04.009","article-title":"Integrin alpha7 is a functional marker and potential therapeutic target in glioblastoma","volume":"21","author":"Haas","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.clineuro.2022.107198_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23034","article-title":"Integrin alpha7 is overexpressed and correlates with higher pathological grade, increased T stage, advanced TNM stage as well as worse survival in clear cell renal cell carcinoma patients: a retrospective study","volume":"34","author":"Chen","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"9","key":"10.1016\/j.clineuro.2022.107198_bib16","first-page":"4630","article-title":"Overexpression of integrin alpha7 correlates with advanced disease condition and poor prognosis in rectal cancer patients","volume":"11","author":"Huang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23082","article-title":"Clinical significance of CD133 and Nestin in astrocytic tumor: the correlation with pathological grade and survival","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.clineuro.2022.107198_bib18","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1038\/ncomms13568","article-title":"Integrin alpha7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma","volume":"7","author":"Ming","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clineuro.2022.107198_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2019.109465","article-title":"Integrin alpha 7 correlates with poor clinical outcomes, and it regulates cell proliferation, apoptosis and stemness via PTK2-PI3K-Akt signaling pathway in hepatocellular carcinoma","volume":"66","author":"Ge","year":"2020","journal-title":"Cell Signal."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib20","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/1061186X.2018.1479756","article-title":"CD133: beyond a cancer stem cell biomarker","volume":"27","author":"Barzegar Behrooz","year":"2019","journal-title":"J. Drug Target"},{"issue":"12","key":"10.1016\/j.clineuro.2022.107198_bib21","doi-asserted-by":"crossref","first-page":"21642","DOI":"10.1002\/jcp.28824","article-title":"New emerging roles of CD133 in cancer stem cell: signaling pathway and miRNA regulation","volume":"234","author":"Aghajani","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107198_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13921","article-title":"Therapeutic implications of immunohistochemical expression pattern of the cancer stem cell marker (nestin) in basal and squamous cell carcinomas","volume":"33","author":"Rabea","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.clineuro.2022.107198_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.biocel.2019.01.002","article-title":"Characterization of OCT3\/4, Nestin, NANOG, CD44 and CD24 as stem cell markers in canine prostate cancer","volume":"108","author":"Costa","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107198_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.clineuro.2022.107198_bib25","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020426","article-title":"A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients","volume":"100","author":"Shen","year":"2021","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clineuro.2022.107198_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.anndiagpath.2013.11.004","article-title":"Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer","volume":"18","author":"Abd El hafez","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.clineuro.2022.107198_bib27","doi-asserted-by":"crossref","first-page":"C876","DOI":"10.1152\/ajpcell.00282.2018","article-title":"Integrin-alpha7 signaling regulates connexin 43, M-cadherin, and myoblast fusion","volume":"316","author":"McClure","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-020-05836-7","article-title":"Identification of candidate mediators of chemoresponse in breast cancer through therapy-driven selection of somatic variants","volume":"183","author":"Al Amri","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.clineuro.2022.107198_bib29","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.3389\/fimmu.2018.02924","article-title":"Cancer stem cells and immunosuppressive microenvironment in glioma","volume":"9","author":"Ma","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clineuro.2022.107198_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.05.001","article-title":"Epigenetic regulation of cancer stem cell and tumorigenesis","volume":"148","author":"Zhu","year":"2020","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"10.1016\/j.clineuro.2022.107198_bib31","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-017-2379-y","article-title":"Molecular markers in glioma","volume":"134","author":"Ludwig","year":"2017","journal-title":"J. Neurooncol."}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846722000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:40:26Z","timestamp":1759588826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846722000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":31,"alternative-id":["S0303846722000798"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107198","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-839387\/v1","asserted-by":"object"}]},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship among integrin alpha 7, CD133 and Nestin as well as their correlation with clinicopathological features and prognosis in astrocytoma patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2022.107198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107198"}}